Abstract

Investigators at Emory University, Atlanta, GA and multiple centers in the USA and UK conducted a prospective study of the effects of antiepileptic drug (AED) monotherapy (carbamazepine, lamotrigine, phenytoin, or valproate) on the intelligence quotient (IQ) at 6 years of age (age-6 IQ).

Highlights

  • Investigators at Emory University, Atlanta, GA and multiple centers in the USA and UK conducted a prospective study of the effects of antiepileptic drug (AED) monotherapy on the intelligence quotient (IQ) at 6 years of age

  • Measures of verbal and memory abilities were lower in children exposed to valproate compared to the other AEDs, and non-verbal and executive functions were lower with valproate compared to lamotrigine

  • High doses of valproate were negatively associated with IQ, verbal ability, non-verbal ability, memory, and executive function; other AEDs were not

Read more

Summary

Introduction

Mutational screening for neonatal and infantile seizures should involve KCNQ2 in both BFNS and BFNIS, and PRRT2 in BFIS families. A clear clinical classification of the seizure phenotype is an essential preliminary to genetic analysis. In addition to confirming a clinical diagnosis, a positive SCN1A mutation will influence treatment and improve seizure control. (Brunklaus A, et al The clinical utility of an SCN1A genetic diagnosis in infantile-onset epilepsy.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.